Key statistics
As of last trade, Akoya Biosciences Inc (AKYA:NSQ) traded at 3.29, 74.73% above the 52 week low of 1.88 set on May 23, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 3.21 |
---|---|
High | 3.29 |
Low | 3.12 |
Bid | 3.27 |
Offer | 3.29 |
Previous close | 3.17 |
Average volume | 125.68k |
---|---|
Shares outstanding | 49.50m |
Free float | 26.33m |
P/E (TTM) | -- |
Market cap | 156.91m USD |
EPS (TTM) | -1.22 USD |
Data delayed at least 15 minutes, as of Nov 11 2024 18:32 GMT.
More ▼
- Akoya Biosciences Unveils a New Era in Spatial Content Innovation with the PhenoCode™ Discovery IO60 and Mouse FFPE IO Panel
- Akoya Bioscience to Report Third Quarter 2024 Financial Results on November 14, 2024
- Akoya’s Leading Spatial Proteomics Platforms Selected for Use by Ground-Breaking UK-Based MANIFEST Consortium to Revolutionize Cancer Immunotherapy
- Akoya Biosciences Announces Scott Mendel as Chairman of the Board of Directors
- Akoya Biosciences Reports Second Quarter 2024 Financial Results
- Akoya Biosciences to Report Second Quarter 2024 Financial Results on August 5, 2024, and Participate at Two Upcoming Investor Conferences
- Akoya Biosciences Reports First Quarter 2024 Financial Results
- Akoya Biosciences and NeraCare Enter into an Exclusive Agreement to Enable Personalized Therapy Selection for Early-Stage Melanoma Patients
- Akoya Biosciences Opens Operations and Manufacturing Center of Excellence in Marlborough, Massachusetts
- Akoya Biosciences and Shanghai KR Pharmtech Announce Chinese Regulatory Agency Premarket Approval for KR-HT5 in China to Support Next Generation Pathology Clinical Workflows
More ▼